US FDA Teases Disclosure Program, But Industry Has Seen This Before

 
• By Derrick Gingery
  
Will consolidation of the FDA's FOIA/disclosure staff limit the resources available to redact documents for public release? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Complete Response Letters

More from Product Reviews